5 December 2016 · This document is aimed at staff in UK NHS hospitals considering or already sourcing their supply of chemotherapy as ready-to-administer doses.
11 November 2019 · This document has been developed by the NHS Quality Assurance Committee and National Pharmacy Clinical Trials Advisory Group with input provided by the MHRA Clinical…
22 October 2020 · This updated Medicines Q&A evaluates the available evidence for the use of erythromycin as a prokinetic agent in adults Summary The ideal prokinetic dose of…